A better ultrasound marker for lymph nodes in breast cancer
Part of Cancer clinical trials.
This trial tests a new ultrasound marker to help surgeons find and remove cancer-positive lymph nodes during breast cancer surgery. The marker makes the node easier to see on ultrasound so it can be taken out accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have breast cancer.
- A biopsy has confirmed that cancer has spread to a lymph node under your arm.
- You are having surgery to remove that lymph node, and your surgeon is part of this study's team.
- You are willing to follow the study procedures for the entire length of the study.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a 3D ultrasound scan to see lymph nodes in people being evaluated for breast cancer. It may help doctors better image lymph nodes during routine care.
This study tests a special “marker” technique to help surgeons find affected lymph nodes in the armpit after chemotherapy. It may support more targeted surgery and help avoid unnecessary removal of healthy lymph nodes.
This trial compares two methods to mark lymph nodes in the armpit after chemotherapy for breast cancer. It tests whether a carbon-based marker works as well as a metallic marker to help surgeons find and remove the right lymph nodes.
This trial tests a new surgical marker called Canopus that helps doctors find and remove breast tumors or affected lymph nodes during surgery. It may help you get more precise treatment.
This trial uses ultrasound to see if an AI tool can better find small markers placed in the breast during a biopsy. It might help improve follow-up care and make future procedures more precise.
This trial compares a new imaging method (LuminoMark) to the usual approach for finding and removing cancer in the lymph nodes under the arm during surgery. It may help doctors more precisely target and remove the affected nodes, which could improve treatment and reduce side effects.
Hear when a new Anatomic Stage II Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.